Monitoring and Population HealthResults, Monitoring and Recalls
Monitoring that follows through to evidence.
A medicine needs blood tests; Reedley links each result to its request and monitoring requirement, keeps follow-up open, and is designed to close it only when a clinician’s review is recorded (in the development build the loop closes when the result is received).
Interactive demonstration
Synthetic patient · pause, step and replay at any point
Susan GREAVES NHS 999 000 2045
Born 11 Mar 1968 · 58 y · Female
Step 1 of 6 · Expected monitoring · Continues as you scroll
- Expected monitoring
- Latest available results In the development build
- Missing evidence
- Review requirement
- Recall and follow-up
- Verified by results
Priadel 400 mg modified-release tablets (lithium carbonate) · two at nightRepeat entry · 8 Oct 2026
Lithium is recorded by brand; SPS notes that preparations differ in bioavailability. SPS · Prescribing by brand
Step 1 · Expected monitoring
Expected monitoring
A draft, unsigned rule for lithium, shown with its sources as intended design, sets what is expected and when. The development build’s draft rule differs: different tests and intervals, and no citations.
Lithium monitoring (draft) v0.3-draft
Draft · unsigned · no named clinical owner · needs clinical sign-off before useDraft practice rule (unsigned, no named owner): serum lithium, U&E with calcium, eGFR, thyroid function and weight or BMI every 6 months after the first year, or lithium every 3 months for the groups in NICE CG185 1.10.20. For this patient, 6-monthly monitoring was recorded by Dr H. MARSH on 14 Apr 2026.
Lithium review · 14 Apr 2026NICE · 1.10.20NICE · 1.10.21
| Test | Interval in the draft rule | Source |
|---|---|---|
| Serum lithium (12-hour post-dose sample) | Every 6 months after the first year; every 3 months for people in any of these groups (NICE CG185 1.10.20; a clinician records which applies):
| NICE · 1.10.20SPS · After started or dose changed |
| U&E including calcium, eGFR | Every 6 months; more often in the circumstances NICE CG185 1.10.21 lists (applied by a clinician) | NICE · 1.10.21 |
| Thyroid function | Every 6 months; more often in the circumstances NICE CG185 1.10.21 lists (applied by a clinician) | NICE · 1.10.21 |
| Weight or BMI | Every 6 months | NICE · 1.10.21 |
Last practice bloods 14 Apr 2026Due by 14 Oct 2026 (6-monthly, as recorded 14 Apr 2026)
Reedley applies the interval a clinician recorded; it does not assess which group applies.
Step 2 · Latest available results In the development build
As reported by the laboratory · no interpretation
The latest results are shown as the laboratory reported them, with the laboratory’s own flags only.
- Serum lithium 0.62 mmol/L, received 14 Apr 2026; no laboratory flags.Results received 14 Apr 2026 16:02Results received 14 Apr 2026 16:02
- U&E and eGFR received 2 Sep 2026 (hospital pathology); next due by 2 Mar 2027 under the draft rule.Results received 2 Sep 2026 12:40Results received 2 Sep 2026 12:40
- Thyroid function: TSH received 14 Apr 2026.Results received 14 Apr 2026 16:02
Step 3 · Missing evidence
Missing evidence
What the rule expects and the record does not show, with the limit of an incomplete feed stated.
- Not found in the available recordNo lithium level found in the available record since 14 Apr 2026.Results received 14 Apr 2026 16:02
- Not found in the available recordNo thyroid function result found in the available record since 14 Apr 2026.Results received 14 Apr 2026 16:02
- Not found in the available recordNo calcium result found in the available record since 14 Apr 2026.Results received 14 Apr 2026 16:02
- An incomplete record or results feed cannot prove a test was not done; the test may have been done elsewhere.
Step 4 · Review requirement
Review requirement
Each received result goes to a clinician through the practice’s own results workflow; this item stays open until a review is recorded.
Lithium monitoring: serum lithium (draft 6-monthly rule)
Admin teamDue by 14 Oct 2026Assigned
Verified only by A serum lithium result received in the record, then a review by a named clinician. Invitation, booking and request do not verify.
Lithium monitoring: adjusted calcium (draft 6-monthly rule)
Admin teamDue by 14 Oct 2026Assigned
Verified only by An adjusted calcium result received in the record, then a review by a named clinician.
Lithium monitoring: thyroid function (draft 6-monthly rule)
Admin teamDue by 14 Oct 2026Assigned
Verified only by A thyroid function result received in the record, then a review by a named clinician.
Lithium monitoring: weight or BMI (draft 6-monthly rule)
Practice nurseDue by 14 Oct 2026Assigned
Verified only by A weight or BMI recorded in the clinical record.
Step 5 · Recall and follow-up
Recall and follow-up
An invitation, a booking and a request are recorded; none of them verifies the test.
- ActionedInvitation sent21 Oct, 10:15Does not verifyInvitation sent 21 Oct 2026 (sent is not read).Invitation sent · 21 Oct 2026
- ActionedBooked23 Oct, 14:30Does not verifyBooked by the patient on 23 Oct 2026 for 29 Oct 2026 (booked is not attended).Booked · 23 Oct 2026
- ActionedRequested29 Oct, 08:52Does not verifyTests requested 29 Oct 2026 (requested is not resulted).Requested · 29 Oct 2026
- VerifiedResult receivedNot in the record yetVerifies
- ClosedReviewed and filedNot in the record yetCloses
PlannedCreating the recall in the practice’s own system
Step 6 · Verified by results
Verified by results
Results received on 30 Oct verify the lithium level and adjusted calcium; the review by a named clinician closes them. Thyroid function stays open.
- ActionedInvitation sent21 Oct, 10:15Does not verifyInvitation sent 21 Oct 2026 (sent is not read).Invitation sent · 21 Oct 2026
- ActionedBooked23 Oct, 14:30Does not verifyBooked by the patient on 23 Oct 2026 for 29 Oct 2026 (booked is not attended).Booked · 23 Oct 2026
- ActionedRequested29 Oct, 08:52Does not verifyTests requested 29 Oct 2026 (requested is not resulted).Requested · 29 Oct 2026
- VerifiedResult received30 Oct, 11:02VerifiesSerum lithium, U&E, calcium and eGFR received 30 Oct 2026 11:02.Results received 30 Oct 2026 11:02
- ClosedReviewed and filed30 Oct, 16:20ClosesReviewed and filed by Dr H. MARSH (synthetic), 30 Oct 2026 16:20.Result review · 30 Oct 2026
- ClosedLithium monitoring: serum lithium (draft 6-monthly rule)Verified 30 Oct, 11:02 (Result received in the record) · Closed 30 Oct, 16:20 (Reviewed and filed by Dr H. MARSH (synthetic))
- ClosedLithium monitoring: adjusted calcium (draft 6-monthly rule)Verified 30 Oct, 11:02 · Closed 30 Oct, 16:20
- ClosedLithium monitoring: weight or BMI (draft 6-monthly rule)Verified 29 Oct, 09:05 (Weight recorded in a consultation) · Closed 29 Oct, 09:05Observation · 29 Oct 2026
- ActionedLithium monitoring: thyroid function (draft 6-monthly rule)Requested 29 Oct 2026; no thyroid function result found in the available record since 14 Apr 2026. Requested is not resulted.
- Not found in the available recordThyroid function not reported on this request: that part stays open.Results received 30 Oct 2026 11:02
Verification from the practice’s live results depends on access to the clinical system that the practice and its system supplier would have to grant; here it is simulated.
Synthetic record
Oldest first · entries arrive as time moves on
Problem
Bipolar affective disorder · since 2019
Results received 14 Apr 2026 16:02
Serum lithium 0.62 mmol/L (laboratory reference 0.4–1.0) · Sodium 139 mmol/L · Potassium 4.3 mmol/L · Creatinine 78 µmol/L · eGFR 74 mL/min/1.73m2 · Adjusted calcium 2.38 mmol/L · TSH 2.1 mU/L · No laboratory flags
Observation
Weight 71 kg · BMI 26.1
Lithium review · Dr Helen MARSH, GP (synthetic)
Lithium review: 6-monthly monitoring agreed; none of the NICE 3-monthly groups recorded. Lithium started 2019 (community mental health team). (Simulated)
Results received 2 Sep 2026 12:40
Sodium 140 mmol/L · Potassium 4.1 mmol/L · Creatinine 81 µmol/L · eGFR 71 mL/min/1.73m2 · No laboratory flags
Repeat entry
Priadel 400 mg modified-release tablets (lithium carbonate) · Two at night · Repeat · Last issued 8 Oct 2026
Invitation sent
Invitation sent: lithium monitoring blood test and weight check. (Simulated)
Booked
Phlebotomy appointment booked by the patient for 29 Oct 2026 08:50. (Simulated)
Requested
Requested: serum lithium (12-hour post-dose sample), U&E, adjusted calcium, eGFR, thyroid function. (Simulated)
Observation
Weight 72 kg · BMI 26.4
Results received 30 Oct 2026 11:02
Serum lithium 0.66 mmol/L (laboratory reference 0.4–1.0) · Sodium 138 mmol/L · Potassium 4.2 mmol/L · Creatinine 80 µmol/L · eGFR 72 mL/min/1.73m2 · Adjusted calcium 2.40 mmol/L · No laboratory flags · Thyroid function: not reported on this request
Result review · Dr Helen MARSH, GP (synthetic)
Lithium monitoring results of 30 Oct 2026 reviewed and filed. (Simulated)
Guidance the draft rule cites 4 passages · NICE and SPS
Guidance the draft rule cites
NICE
After the first year, measure plasma lithium levels every 6 months, or every 3 months for people in any of the following groups:
NICE
Measure the person's weight or BMI and arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR) and thyroid function every 6 months, and more often if there is evidence of impaired renal or thyroid function, raised calcium levels or an increase in mood symptoms that might be related to impaired thyroid function.
NHS Specialist Pharmacy Service (last updated 6 Dec 2024)
Preparations vary widely in bioavailability and therefore should be prescribed by brand.
NHS Specialist Pharmacy Service (last updated 6 Dec 2024)
take sample just prior to time of next dose (i.e. trough level 12 hours following last dose)
Synthetic demonstration · fictional patient, clinicians and organisations · NHS number in the 999 test range · Not connected to any clinical system · Nothing is written to a medication record
Illustrative demonstration · intended workflow, except steps marked In the development build · Scripted reconstruction: the development build itself is not running on this page.
- Results shown as the laboratory reported them, linked to the monitoring requirement.
- Missing results stay visible, with what was searched.
- Follow-up and recall steps show what happened, and what has not yet.
From what arrives to what you decide
- What entersA medicine that needs blood tests
- What Reedley preparesEach result linked to its request and monitoring requirement; follow-up kept open
- What the clinician decidesA clinician reviews; follow-up is designed to close only when that review is recorded
What it does not do · what exists today
- Reedley does not interpret results or decide which results a clinician sees: the practice’s own results workflow is unchanged.
- In the development build, a result received in the record is shown as reported and linked to the monitoring requirement it satisfies, and draft-rule monitoring work is created. There, a follow-up loop closes when the result is received, without waiting for a recorded review. Recall creation and invitations are planned.
- Monitoring rules in the development build are drafts with no clinical owner and no source citations, and they differ from national (SPS) guidance; the cited rule in the demonstration is illustrative.
Every patient shown is synthetic. No integration with a clinical system is claimed, and no clinician has yet used Reedley in practice. Safety and governance
See it with your own work in mind.
Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.